News Report | January 18, 2010
Rules-Based Medicine Files for IPO
OPEN MINDS Weekly News Wire
Mental Health & Chemical Dependency Services
On December 23, 2009, psychiatric biomarker developer Rules-Based Medicine, Inc., in Austin, Texas filed documents with the United States Security and Exchange Commission (SEC) to offer its stock to the public in an Initial Public Offering (IPO) slated for mid-2010. The company seeks to raise $90 million. It applied to list its stock on the NASDAQ Global Market under the symbol RULE. Founded in 2002, Rules-Based Medicine develops tests to identify biomarkersproteins in body fluids unique . . .